How does 6846's PB Ratio compare to its peers?

Insufficient data to calculate 6846's Price-To-Book Ratio vs. peers for valuation analysis.

How does 6846's PB Ratio compare vs other companies in the TW Personal Products Industry?

Insufficient data to calculate 6846's Price-To-Book Ratio vs. industry for valuation analysis.

What is 6846's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate 6846's Price-To-Book Fair Ratio for valuation analysis.

What is the Fair Price of 6846 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate 6846's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

6846 Stock Overview

A dietary supplement company, develops, manufactures, and sells health products in Taiwan and internationally. More details

6846 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	2/6

Risk Analysis

Has not reported any financial data

Does not have a meaningful market cap (NT$2B)

My Notes

Capture your thoughts, links and company narrative

Greenyn Biotechnology Co., Ltd Competitors

GeneFerm Biotechnology

TPEX:1796

NT$2.0b

Jia Jie Biomedical

TPEX:4109

NT$2.2b

Hantech Bio-Technology

TPEX:1294

NT$2.5b

Luo Lih-Fen Holding

TWSE:6666

NT$2.4b

Price History & Performance

Summary of share price highs, lows and changes for Greenyn Biotechnology
Historical stock prices
Current Share Price	NT$76.70
52 Week High	NT$84.00
52 Week Low	NT$71.00
Beta	0
1 Month Change	1.59%
3 Month Change	1.59%
1 Year Change	-3.52%
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-7.59%

Recent updates

Shareholder Returns

	6846	TW Personal Products	TW Market
7D	1.6%	-3.3%	0.9%
1Y	-3.5%	-19.7%	28.9%

Return vs Industry: 6846 exceeded the TW Personal Products industry which returned -19.7% over the past year.

Return vs Market: 6846 underperformed the TW Market which returned 28.9% over the past year.

Price Volatility

Is 6846's price volatile compared to industry and market?
6846 volatility
6846 Average Weekly Movement	2.7%
Personal Products Industry Average Movement	4.0%
Market Average Movement	4.5%
10% most volatile stocks in TW Market	7.8%
10% least volatile stocks in TW Market	2.1%

Stable Share Price: 6846 has not had significant price volatility in the past 3 months compared to the TW market.

Volatility Over Time: 6846's weekly volatility (3%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
2012	n/a	n/a	www.greenynbio.com

Greenyn Biotechnology Co., Ltd, a dietary supplement company, develops, manufactures, and sells health products in Taiwan and internationally. The company offers proprietary ingredients, such as Insumate, a bitter melon extract; Antromax, an antrodia cinnamomea; and Zymologist 101 Phyto fermented drink. It also provides functional formulas for youth and beauty series, digestive health series, brain health series, body regulation series, throat moistening series, hair care series, clear eye series, colorful lifestyle series, joint health series, nutritional supplement series, energy supplement series, immune modulation series, low burden series, sleep aid series, body curve series, circulation series, man power series, women’s intimate health series, and mature woman series.

Greenyn Biotechnology Co., Ltd Fundamentals Summary

How do Greenyn Biotechnology's earnings and revenue compare to its market cap?
6846 fundamental statistics
Market cap	NT$2.08b
Earnings (TTM)	NT$0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is 6846 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
6846 income statement (TTM)
Revenue	NT$0
Cost of Revenue	NT$0
Gross Profit	NT$0
Other Expenses	NT$0
Earnings	NT$0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did 6846 perform over the long term?

See historical performance and comparison

Dividends

4.6%

Current Dividend Yield

n/a

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/19 08:58
End of Day Share Price	2024/12/19 00:00
Earnings	N/A
Annual Earnings	N/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Greenyn Biotechnology Co., Ltd is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Jianzheng Wu	Capital Securities Corporation

Greenyn Biotechnology TPEX:6846 Stock Report